Damien Hirst Sculptures For Sale

Damien Hirst Sculptures

Market Authority and Collector Demand

Damien Hirst's sculptural works represent the most commanding segment of his market, with three-dimensional pieces consistently achieving the highest valuations among his diverse oeuvre. Guy Hepner, with $4,226,125 in documented Damien Hirst transactions, offers collectors direct access to authenticated sculptures from the artist's celebrated pharmaceutical series. The global art market's return to growth in 2025, as documented by Art Basel and UBS in their 2026 report, has intensified demand for blue-chip sculptural works that demonstrate both conceptual depth and material presence.

Hirst's position as the leading figure of the Young British Artists movement, combined with authentication through Science Ltd and representation by White Cube, establishes an institutional framework that supports sustained market confidence. His landmark "Beautiful Inside My Head Forever" single-artist auction at Sotheby's in 2008—which achieved $198 million in total sales—demonstrated unprecedented collector appetite for his sculptural editions. Lullaby Spring, selling for $19.2 million at Sotheby's in 2007, remains a touchstone for understanding the premium commanded by Hirst's three-dimensional pharmaceutical works.

Series Context and Conceptual Framework

The pill sculptures represent Hirst's most direct engagement with pharmaceutical iconography as freestanding objects. Departing from the cabinet-based installations of his pharmacy works, these individual pill forms isolate the symbolic power of medication, transforming clinical objects into monuments of contemporary anxiety, hope, and consumption. Each sculpture functions as both portrait and commentary—capturing the specific visual identity of branded pharmaceuticals while questioning the cultural mythologies surrounding healing, dependency, and the body.

Executed in 2014, this series emerged during a period of renewed sculptural focus in Hirst's practice, following his exploration of large-scale installations and painted works. The selection of specific medications—from cardiovascular treatments to antibiotics to common decongestants—reveals a systematic cataloguing of the contemporary medicine cabinet. These works participate in a tradition extending from Pop Art's engagement with consumer products through to Hirst's own formaldehyde vitrines, yet they achieve a formal clarity and chromatic intensity that distinguishes them within his broader output.

The pharmaceutical industry's visual language—precise colors, embossed typography, geometric forms—provides Hirst with a ready-made aesthetic vocabulary that he amplifies to monumental scale. In doing so, the sculptures collapse distinctions between fine art, industrial design, and medical commerce.

Technical Specifications and Material Analysis

Each sculpture in this collection utilizes polyurethane resin with ink pigment, a medium that achieves exceptional color saturation and surface finish. This industrial material choice aligns conceptually with pharmaceutical manufacturing processes while enabling the precise replication of pill forms at dramatically increased scale. The resin captures light with a luminosity that recalls the glossy coatings of actual medications, creating objects that oscillate between sculpture and oversized replica.

The chromatic range demonstrates remarkable specificity. VISKEN 5 and Pfizer 100mg in baby blue reference the calming associations of pharmaceutical branding, while Valium 5MG Roche in yellow captures the distinctive identity of one of the twentieth century's most culturally significant medications. The pink variant of Pfizer 100mg offers chromatic variation within the brand identity, while Sudafed PE in clear polyurethane resin introduces transparency as both material quality and potential metaphor for bodily permeability.

Surface detailing includes pharmaceutical typography and manufacturer markings rendered with technical precision. These inscriptions—brand names, dosage specifications, company identifiers—become sculptural elements in themselves, embossed or imprinted text that transforms medical information into aesthetic content. The works range in scale while maintaining proportional accuracy to their pharmaceutical sources, ensuring recognizability regardless of dimensional amplification.

Notable Works from the Collection

Valium 5MG Roche (Yellow) commands particular significance given Valium's cultural history as both legitimate treatment and symbol of mid-century anxieties regarding medication dependency. The yellow coloration directly references Roche's iconic branding, making this work instantly recognizable to audiences familiar with pharmaceutical visual culture.

Pfizer 100mg in both baby blue and pink iterations engages with one of the most commercially successful and culturally discussed medications of recent decades. These works carry associations extending beyond pharmaceutical function into broader conversations about masculinity, performance, and bodily intervention.

Sudafed PE in clear polyurethane resin offers a distinctive material approach within the series, its transparency creating complex interactions with ambient light and viewing environment. This technical variation provides collectors with an alternative visual experience while maintaining conceptual continuity.

Investment Analysis and Market Position

Hirst's sculptural market demonstrates resilience and consistent institutional support. Major auction houses including Christie's, Sotheby's, Phillips, and Bonhams regularly feature his three-dimensional works in contemporary sales, with pharmaceutical sculptures attracting particular collector interest. The 2024 global art market's $57.5 billion total, as reported by Art Basel and UBS, indicates sustained capital allocation to blue-chip contemporary artists.

Edition works from established series offer collectors entry to Hirst's sculptural practice at accessible price points while maintaining authentication standards through Science Ltd. The pharmaceutical sculptures benefit from immediate visual impact and conceptual accessibility, qualities that support both private collection display and institutional consideration.

Secondary market activity confirms ongoing demand for Hirst's sculptural editions, with works from recognizable series achieving consistent results at auction. The 2014 production date provides sufficient market history for evaluating performance while maintaining contemporary relevance.

Acquisition Through Guy Hepner

Guy Hepner in New York provides authenticated access to Damien Hirst sculptures with comprehensive provenance documentation and Science Ltd verification. Our transaction history of $4,226,125 in Hirst works demonstrates established relationships with collectors seeking museum-quality contemporary sculpture.

Each acquisition includes condition reporting, authentication materials, and guidance regarding display considerations for polyurethane resin works. Contact Guy Hepner to discuss available sculptures and current market positioning for these significant examples of Hirst's pharmaceutical series.